COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity
Article
[키워드] age
antibody
Cohort
Comorbidities
COVID-19
COVID-19 severity
Critical
cumulative
described
died
disease
Factor
Follow-up
Frequency
General population
high risk
higher risk
Immunosuppression
incidence
increased risk
infected with SARS-CoV-2
islet
islet transplantation
kidney
kidney transplant
less
Luciferase immunoprecipitation system
Mild
moderate
Mortality
mortality rate
nine
not different
organ
outcome
pancrea
pancreas transplantation
Patient
patient population
positive
Prevalence
Protective
recipient
recipients
Risk factors
San Raffaele Hospital
SARS-CoV-2
SARS-CoV-2 antibody
SARS-COV-2 infection
SARS-CoV-2 RT-PCR
Seroprevalence
severe disease
simple
Solid
solid organ
solid organ transplant
SOT
study period
symptomatic
tested
the SARS-CoV-2
the WHO
therapy
Transplant
transplants
yielding
[DOI] 10.3390/biology10121349 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biology10121349 PMC 바로가기 [Article Type] Article